Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2531003687', 'doi': None, 'title': 'Key regulatory issues in the development of pharmabiotics in Europe', 'display_name': 'Key regulatory issues in the development of pharmabiotics in Europe', 'publication_year': 2016, 'publication_date': '2016-01-07', 'ids': {'openalex': 'https://openalex.org/W2531003687', 'mag': '2531003687'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://www.omicsonline.org/proceedings/key-regulatory-issues-in-the-development-of-pharmabiotics-in-europe-40775.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764495348', 'display_name': 'Journal of Probiotics & Health', 'issn_l': '2329-8901', 'issn': ['2329-8901'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320466', 'host_organization_name': 'OMICS Publishing Group', 'host_organization_lineage': ['https://openalex.org/P4310320466'], 'host_organization_lineage_names': ['OMICS Publishing Group'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5031149605', 'display_name': 'Luis Gosalbez', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Luis Gosalbez', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5031149605'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12255', 'display_name': 'Immunogenicity of Biosimilar Therapeutics in Drug Development', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12255', 'display_name': 'Immunogenicity of Biosimilar Therapeutics in Drug Development', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11792', 'display_name': 'Economics of Pharmaceutical Research and Development', 'score': 0.9742, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T12547', 'display_name': 'Developmental Pharmacology in Pediatric Drug Use', 'score': 0.9359, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pharmaceutical-innovation', 'display_name': 'Pharmaceutical Innovation', 'score': 0.479148}], 'concepts': [{'id': 'https://openalex.org/C26517878', 'wikidata': 'https://www.wikidata.org/wiki/Q228039', 'display_name': 'Key (lock)', 'level': 2, 'score': 0.7437688}, {'id': 'https://openalex.org/C2522767166', 'wikidata': 'https://www.wikidata.org/wiki/Q2374463', 'display_name': 'Data science', 'level': 1, 'score': 0.39478028}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.37510115}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.32985136}, {'id': 'https://openalex.org/C55587333', 'wikidata': 'https://www.wikidata.org/wiki/Q1133029', 'display_name': 'Engineering ethics', 'level': 1, 'score': 0.32167327}, {'id': 'https://openalex.org/C127413603', 'wikidata': 'https://www.wikidata.org/wiki/Q11023', 'display_name': 'Engineering', 'level': 0, 'score': 0.13899407}, {'id': 'https://openalex.org/C38652104', 'wikidata': 'https://www.wikidata.org/wiki/Q3510521', 'display_name': 'Computer security', 'level': 1, 'score': 0.11868799}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://www.omicsonline.org/proceedings/key-regulatory-issues-in-the-development-of-pharmabiotics-in-europe-40775.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764495348', 'display_name': 'Journal of Probiotics & Health', 'issn_l': '2329-8901', 'issn': ['2329-8901'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320466', 'host_organization_name': 'OMICS Publishing Group', 'host_organization_lineage': ['https://openalex.org/P4310320466'], 'host_organization_lineage_names': ['OMICS Publishing Group'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/17', 'score': 0.43, 'display_name': 'Partnerships for the goals'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2780152204', 'https://openalex.org/W2768768094', 'https://openalex.org/W2612978946', 'https://openalex.org/W2612842664', 'https://openalex.org/W2607711055', 'https://openalex.org/W2606533226', 'https://openalex.org/W2601664171', 'https://openalex.org/W2600895802', 'https://openalex.org/W2598799501', 'https://openalex.org/W2587567236', 'https://openalex.org/W2550779801', 'https://openalex.org/W2545648980', 'https://openalex.org/W2535769253', 'https://openalex.org/W2530669593', 'https://openalex.org/W2527810778', 'https://openalex.org/W2527737993', 'https://openalex.org/W2527400409', 'https://openalex.org/W2524574978', 'https://openalex.org/W2509109670', 'https://openalex.org/W2317750469'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2531003687', 'counts_by_year': [], 'updated_date': '2024-09-24T20:25:59.164782', 'created_date': '2016-10-21'}